Tirzepatide (20 mg/30 mg)

Tirzepatide – Research Peptide

Tirzepatide is a dual-receptor agonist peptide studied for its activity at both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This combined mechanism makes it a compound of significant interest in metabolic and endocrine research, particularly in studies exploring glucose regulation and energy balance.

In laboratory settings, Tirzepatide is investigated for its effects on insulin signaling, glucose metabolism, and appetite-related pathways. By engaging both GIP and GLP-1 receptors, it allows researchers to examine the synergistic impact of dual incretin activation on metabolic efficiency and nutrient utilization.

Preclinical and investigational research has explored Tirzepatide in relation to body composition, satiety signaling, and lipid metabolism. It is also studied for its potential influence on insulin sensitivity, postprandial glucose control, and broader cardiometabolic markers in experimental models.

Key specifications:

• Purity: 99%
• Form: Lyophilized powder

Key Research Areas:

Dual incretin receptor activation (GIP and GLP-1)

Glucose metabolism and insulin response

Appetite regulation and satiety signaling

Body composition and weight regulation studies

Lipid metabolism and cardiometabolic research

Important Notice:

Supplied by Analogue Peptides, Tirzepatide is a research-grade peptide intended strictly for research only. It is not a cosmetic, supplement, or medication, and is not intended for human consumption, therapeutic application, or clinical use.

Dual incretin peptide, GLP-1 GIP receptor agonist, metabolic regulation compound, glucose control research, appetite signaling peptide, weight management studies, laboratory research use only.

All compounds are supplied as lyophilized (freeze-dried) powder to support stability during storage and shipping. Products are intended for laboratory research purposes only.